163 related articles for article (PubMed ID: 15979702)
21. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
22. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
[TBL] [Abstract][Full Text] [Related]
23. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
Shman TV; Belevtsev MV; Buglova SE
Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010
[TBL] [Abstract][Full Text] [Related]
24. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells.
Rizzi M; Tschan MP; Britschgi C; Britschgi A; Hügli B; Grob TJ; Leupin N; Mueller BU; Simon HU; Ziemiecki A; Torbett BE; Fey MF; Tobler A
J Leukoc Biol; 2007 Jun; 81(6):1599-608. PubMed ID: 17347302
[TBL] [Abstract][Full Text] [Related]
25. Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse.
Weinberg JB; Misukonis MA
Cancer Res; 1984 Dec; 44(12 Pt 1):5594-8. PubMed ID: 6594193
[TBL] [Abstract][Full Text] [Related]
26. High remission rate in acute myeloblastic leukemia in children treated with high-dose methylprednisolone.
Hicsönmez G; Karadeniz N; Zamani VP; Tuncer AM; Gümrük F; Erturk G; Gurgey A; Ozsoylu S
Eur J Haematol; 1992 Apr; 48(4):215-20. PubMed ID: 1592102
[TBL] [Abstract][Full Text] [Related]
27. Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S; Tuncer AM; Ertürk G; Ozbek N; Karadeniz N
Exp Hematol; 1991 Mar; 19(3):232-3. PubMed ID: 1995314
[No Abstract] [Full Text] [Related]
28. HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells.
Song G; Liao X; Zhou L; Wu L; Feng Y; Han ZC
Leuk Res; 2004 Oct; 28(10):1089-96. PubMed ID: 15289023
[TBL] [Abstract][Full Text] [Related]
29. Effects of methylprednisolone on human myeloid leukemic cells in vitro.
Ozbek N; Erdemli E; Hiçsönmez G; Okur H; Tekelioğlu M
Am J Hematol; 1999 Apr; 60(4):255-9. PubMed ID: 10203097
[TBL] [Abstract][Full Text] [Related]
30. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
[TBL] [Abstract][Full Text] [Related]
31. New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.
Bruserud O; Gjertsen BT
Stem Cells; 2000; 18(3):157-65. PubMed ID: 10840068
[TBL] [Abstract][Full Text] [Related]
32. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever.
Dilber E; Cakir M; Erduran E; Koksal I; Bahat E; Mutlu M; Celtik AY; Okten A
Trop Doct; 2010 Jan; 40(1):27-30. PubMed ID: 20075424
[TBL] [Abstract][Full Text] [Related]
33. Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells.
Vitale C; Cottalasso F; Montaldo E; Moretta L; Mingari MC
Int Immunol; 2008 Apr; 20(4):565-75. PubMed ID: 18310065
[TBL] [Abstract][Full Text] [Related]
34. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
35. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
36. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
38. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
39. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
[TBL] [Abstract][Full Text] [Related]
40. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
